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Abstract 
This study determined the effects of acute treatment with morphine on the expression of the Oprm1, Oprk1, and 
Oprd1 genes (which encode μ, κ, and δ receptors, respectively) in the striatum, hypothalamus, and periaqueductal 
gray (PAG) in ovariectomized female rats treated with estrogen. Ovariectomized female rats were divided into five 
equal groups. Two groups received estrogen (50 µg/kg, 54 h before testing) and saline (ES group) or 3.5 mg/kg mor-
phine (EM group) 2 h before euthanasia. The SS group received saline solution 54 and 2 h before the experiments. 
The SM group received saline 54 h and 3.5 mg/kg morphine 2 h before the experiments. The W group remained 
undisturbed. The genes expression were evaluated. Oprm1 and Oprk1 expression were activated, respectively, in the 
hypothalamus and PAG and in the striatum and PAG by morphine only in estrogen-treated animals. Oprd1 expression 
in the hypothalamus and PAG was activated by morphine in both estrogen-treated and -nontreated animals. The 
Oprm1 and Oprk1 gene response to morphine might depend on estrogen, whereas the Oprd1 gene response to mor-
phine might not depend on estrogen, supporting the hypothesis of a functional role for ovarian hormones in opioid 
receptor-mediated functional adaptations in the female brain.
Keywords: Opioid, Estrogen, Progesterone, Striatum, Hypothalamus, Periaqueductal gray
© 2015 Cruz et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Female gonadal hormones have an important impact on 
many brain functions and behaviors related to reproduc-
tion and neurotransmission in some brain sites. These 
pathways exist through direct binding to specific mem-
brane receptors or through an indirect action via genetic 
mechanisms and differences in gene expression and pro-
tein content (Wilson and Westberry 2009). The regula-
tion of pituitary gonadotropin secretion may result from 
a complex interaction between a gonadal steroid feed-
back mechanism and the influence of brain neurotrans-
mitter systems in the hypothalamic–pituitary system, 
including the opioidergic system (Kalra 1993; Wójcik-
Gładysz et al. 2006; Kaminski et al. 2004; Yilmaz and Gil-
more 2000).
Endogenous opioids can modulate the catecholamine 
pathway, inhibit catecholamine release during times of 
stress, and inhibit gonadotropin secretion (Angelopou-
los et al. 1995). Opioid receptors can have various effects 
that depend on their localization in the brain. The anal-
gesic activity of these receptors has been observed in 
the spinal cord and brainstem. In regions of the striatum 
and hypothalamus, they appear to modulate motor and 
reproductive function, respectively (Hammer et al. 1994; 
Teodorov et  al. 2006, 2014; Miranda-Paiva et  al. 2007; 
Yim et al. 2006; Sukikara et al. 2006).
The opioidergic system plays roles at both central and 
peripheral sites. At central sites, the opioidergic sys-
tem plays a critical role in reproductive neuroendocrine 
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function, whereas peripheral actions on carbohydrate 
metabolism and insulin resistance have been reported 
(Fulghesu et  al. 2001). β-endorphin plays a modulatory 
role by inhibiting gonadotropin-releasing hormone and 
luteinizing hormone (LH) release from the pituitary. 
Other studies showed that the increase in opioidergic 
system activity in patients with polycystic ovary syn-
drome was suppressed by opioidergic antagonist admin-
istration (Zangeneh et al. 2011). Indeed, κ- and δ-opioid 
receptors have been well studied and appear to be associ-
ated with the control of gonadotropin secretion (Pfeiffer 
et al. 1987; Micevych et al. 2003; Sinchak et al. 2004).
Few studies have investigated the role of opioid recep-
tor subtypes in different regions of the rat brain with 
regard to how steroid hormones act in this context. 
Important studies have been conducted with regard to 
μ-opioid receptors. The number of these receptors in the 
rat brain was found to fluctuate during different phases 
of the estrous cycle (Casulari et  al. 1987; Stoffel et  al. 
2005), and this phenomenon could explain the different 
pathways of the effects that modulate the release of gon-
adotropins by opioidergic agonists and antagonists dur-
ing different phases of the estrous cycle (Kalra et al. 1993; 
Piva et al. 1985).
The present study evaluated the modulatory role of 
morphine and steroid hormones in ovariectomized 
(OVX) virgin rats with regard to Oprm1, Oprk1, and 
Oprd1 gene expression in the PAG, striatum, and hypo-
thalamus because these regions are involved in the con-
trol of motivated, motor, and reproductive behaviors.
Results
Oprm1 gene expression (Figure  1) was signifi-
cantly increased in the EM group in the hypothala-
mus (F =  2.98, df =  15, p =  0.05; Figure  1b) and PAG 
(F = 3.112, df = 15, p = 0.047; Figure 1c) compared with 
the SS group. No significant differences in Oprm1 gene 
expression were found in the striatum between groups 
(F = 0.379, df = 15, p = 1.122; Figure 1a).
Oprk1 gene expression (Figure  2) was significantly 
increased in the EM group in the striatum (F  =  2.855, 
df  =  15, p  =  0.061; Figure  2a) and PAG (F  =  3.353, 
df  =  15, p  =  0.032; Figure  2c) compared with the SS 
group. No differences in Oprk1 gene expression were 
found in the hypothalamus between groups (F =  2.383, 
df = 15, p = 0.078; Figure 2b).
Oprd1 gene expression (Figure  3) was significantly 
increased in the SM and EM groups in the hypothala-
mus (F = 0.757, df = 15, p = 0.569; Figure 3b) and PAG 
(F = 4.473, df = 15, p = 0.014; Figure 3c) compared with 
the SS group (Figure  1c). No differences in Oprd1 gene 
expression were found in the striatum between groups 
(F = 0.757, df = 15, p = 0.569; Figure 3a).
Discussion
In rodents, hormone fluctuations characterize each 
estrous phase as proestrus, estrus, metestrus, and dies-
trus. Studies have shown that a low level of estrogen 
during diestrus has an inhibitory action on the hypo-
thalamus and pituitary (Kirkpatrick and Clark 2011; Piva 
et  al. 1985), and gonadotropin release does not occur 
(Danforth et al. 1990). A gradual increase in estrogen lev-
els is observed during the late stage of diestrus. In proes-
trus, a rapid increase in estrogen and progesterone levels 
Figure 1 Expression of Oprm1 gene in the striatum (a), hypothala-
mus (b), and PAG (c) in OVX female rats. The W group remained 
undisturbed. The SS group received saline solution 54 and 2 h before 
the experiments. The SM group received saline 54 h and 3.5 mg/
kg morphine 2 h before the experiments. The ES group received 
estrogen (50 µg/kg, i.p.) 54 h before testing and saline 2 h before 
the experiments. The EM group received estrogen (50 µg/kg, i.p.) 
54 h before testing and 3.5 mg/kg morphine 2 h before the experi-
ments. *p < 0.05, compared with SS group. The data are expressed as 
mean ± SEM (ANOVA followed by Tukey’s multiple-comparison test).
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occurs, resulting in LH release that enables ovulation 
(Gómez-Camarillo et al. 2011; Gordon et al. 2011; Alva-
renga et al. 2010).
The present study investigated the role of acute estro-
gen administration on opioid gene expression in the 
striatum, hypothalamus, and PAG and the effects of 
acute morphine treatment. To avoid the possible effects 
of endogenous ovarian hormones, we used OVX rats 
and subjected them to experimentation after 15 days to 
elicit total hormone depletion (Rachman et  al. 1998). 
Importantly, adrenal hormones were not considered in 
this study. Thus, OVX female rats were used as an ani-
mal model to study the influence of estrogen replacement 
on the activity of the genes that encode opioid receptors 
in female rats in response to morphine in different brain 
areas. Studies have shown that the restoration of repro-
ductive behavior and changes in gene expression in OVX 
rats occur within 7 days of continuous estrogen replace-
ment, supporting the procedure used in the present study 
Figure 2 Expression of Oprk1 gene in the striatum (a), hypothala-
mus (b), and PAG (c) in OVX female rats. The W group remained 
undisturbed. The SS group received saline solution 54 and 2 h before 
the experiments. The SM group received saline 54 h and 3.5 mg/
kg morphine 2 h before the experiments. The ES group received 
estrogen (50 µg/kg, i.p.) 54 h before testing and saline 2 h before 
the experiments. The EM group received estrogen (50 µg/kg, i.p.) 
54 h before testing and 3.5 mg/kg morphine 2 h before the experi-
ments. *p < 0.05, compared with SS group. The data are expressed as 
mean ± SEM (ANOVA followed by Tukey’s multiple-comparison test).
Figure 3 Expression of Oprd1 gene in the striatum (a), hypothala-
mus (b), and PAG (c) in OVX female rats. The W group remained 
undisturbed. The SS group received saline solution 54 and 2 h before 
the experiments. The SM group received saline 54 h and 3.5 mg/
kg morphine 2 h before the experiments. The ES group received 
estrogen (50 µg/kg, i.p.) 54 h before testing and saline 2 h before 
the experiments. The EM group received estrogen (50 µg/kg, i.p.) 
54 h before testing and 3.5 mg/kg morphine 2 h before the experi-
ments. *p < 0.05, compared with SS group. The data are expressed as 
mean ± SEM (ANOVA followed by Tukey’s multiple-comparison test).
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with regard to the hormonal depletion protocol followed 
by replacement. The doses of morphine and estrogen 
hormones used in this study were previously validated 
in our laboratory and standardized for behavioral and 
molecular analyses (Teodorov et al. 2006, 2011, 2014).
Studies have evaluated the density of μ-, κ-, and 
δ-opioid receptors in many brain structures in rats (Man-
sour et al. 1994, 1995), demonstrating a basal pattern. A 
high density of μ-opioid receptors is found in the PAG. 
A moderate density is found in the striatum, and less 
expression is found in the hypothalamus. A high density 
of κ-opioid receptors is found in the hypothalamus, with 
less expression in the striatum and PAG. A high density 
of δ-opioid receptors is found in the striatum, with less 
density in the PAG and hypothalamus.
Weiland and Wise (1990) showed that steroid hor-
mones modulate opioid receptor density in specific 
brain regions. Their results showed negative and positive 
feedback actions of estrogen and progesterone in hypo-
thalamic regions that regulate gonadotropin release and 
sexual behavior. These actions may be partially mediated 
by the endogenous opioid system. Estrogen and proges-
terone suppress physiological responses to the adminis-
tration of opioid peptides.
The present study evaluated the basal pattern of 
Oprm1, Oprk1, and Oprd1 gene expression in female 
rat brain sites that are known to be involved in repro-
ductive behavior, including the striatum (i.e., important 
role in motor patterns during mating and lactation), PAG 
(i.e., role in nociception, behavioral selection for moti-
vated behaviors, and sexual and maternal behavior), and 
hypothalamus (i.e., role in the modulation of hormonal 
aspects) (Sewards and Sewards 2003; Moura et al. 2010; 
Mota-Ortiz et  al. 2012; Teodorov 2012). Studies have 
shown that estrogen is able to change the action of the 
opioidergic system in rodents by modulating nociceptive 
responses to treatment with naloxone, altering the bind-
ing of opioid receptors in specific brain regions, and 
increasing the rate of internalization of these receptors, 
particularly in morphine studies (Hammer 1990; Gordon 
and Soliman 1996; Aloisi and Ceccarelli 1999; Micevych 
et  al. 2003). Terner et  al. (2005) showed that morphine 
and the semi-synthetic opioid derivative buprenorphine 
dose-dependently increased the patterns of nociception 
in rats, and morphine exerted these effects during all 
phases of the estrous cycle, whereas buprenorphine was 
effective only during estrus.
In the present study, Oprm1 gene expression in the 
hypothalamus and PAG was activated by morphine only 
in estrogen-treated animals. Oprk1 gene expression in 
the striatum and PAG was activated by morphine only 
in estrogen-treated animals. Oprd1 gene expression in 
the hypothalamus and PAG was activated by morphine 
in both estrogen-treated and -nontreated animals. These 
results suggest that the Oprm1 and Oprk1 gene responses 
to morphine might depend on estrogen, whereas the 
Oprd1 gene response to morphine might not depend 
on estrogen. On this respect, κ receptors of the PAG 
have been show to be functionally involved in motivated 
behaviors during the post-partum phase (Mota-Ortiz 
et al. 2012; Teodorov 2012). Recently, a functional inter-
action between μ and κ opioid receptor subtypes has 
been demonstrated (Klein et  al. 2014). Since, this find-
ing was observed in a post-partum scenario, the fact 
that those receptors subtypes were found to be particu-
larly sensitive to estrogen modulation actions might be 
another piece of these puzzle that tell us about the mul-
tiple functional interactions that those to versatile opioid 
receptor subtypes. These data support the hypothesis of a 
functional role for ovarian hormones in opioid receptor-
mediated functional adaptations in the female brain.
Methods
Animals
Female Wistar rats, weighing 200–250  g at the begin-
ning of the study, were obtained from the Faculdade 
de Medicina Veterinária, Universidade de São Paulo. 
The animals were housed in polypropylene cages 
(32 ×  40 ×  18  cm), with three animals per cage under 
controlled temperature (22  ±  2°C) and a 12  h/12  h 
light/dark cycle (lights on 6:00 AM) with free access to 
food and water during the experimental procedure. We 
attempted to minimize the number of rats used, and 
every effort was made to ensure that no rat suffered 
unnecessarily.
Drugs
Morphine sulfate (3.5  mg/kg; Cristalia) was diluted in 
0.9% saline, and the same vehicle was used as a control 
group. The hormones (progesterone and estradiol ben-
zoate; Sigma-Aldrich (Brazil) were diluted in peanut oil. 
All of the injections were administered subcutaneously in 
the dorsal region of the animals.
Molecular studies
RNA extraction, cDNA synthesis, and real-time poly-
merase chain reaction (PCR) were used for the quanti-
fication of opioid receptor gene expression. Total RNA 
was extracted from each tissue sample using Trizol rea-
gent (Invitrogen Life Technologies, Carlsbad, CA, USA). 
Immediately after euthanasia by decapitation, the stria-
tum was suspended in 1  ml ice-cold Trizol, and total 
RNA was extracted according to the manufacturer’s 
instructions. This area was chosen because it modulates 
motor function and opioid dependence (Thompson et al. 
2000; Georges 1999) and has a high density of opioid 
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receptors. The final RNA pellets were resuspended in 
50  μl of diethyl pyrocarbonate-treated water. The total 
RNA concentrations were measured spectrophotomet-
rically at 260 nm, and the integrity of the RNA samples 
was analyzed on 1.5% agarose gel (Sigma, St. Louis, MO, 
USA) that contained 0.5 μg/ml ethidium bromide. Total 
RNA was then treated with DNAse I and stored at −80°C 
until further processing. Real-time PCR was performed 
in a Rotor Gene 3000 instrument (Corbet) using TaqMan 
Universal Master Mix (Applied Biosystems, catalog no. 
4304437). The PCR primers and TaqMan probes for the 
opioid receptor genes Oprm1, Oprk1, and Oprd1 were 
selected using Primer Express software (Applied Bio-
systems), verified by a BLAST search of GenBank, and 
labeled Rn00565144_m1 for Oprm1, Rn00567737_m1 
for Oprk1, RN00561699_m1 for Oprd1, and 4319413E 
for 18S (used as a housekeeping control). The primers 
were chosen to amplify a 65-bp fragment. The internal 
TaqMan probe [FAM-3′-TCTGGGCACCTCTCTTT-5′-
non-fluorescent quencher (NFQ)] was designed accord-
ing to the general rules outlined by the manufacturer 
and carried a 5′ reporter dye, 6-carboxy fluorescein 
(FAM), and 3′ NFQ. The primers and probes were used 
with 100% efficiency at final concentrations of 0.9 and 
0.25 μM, respectively.
Experimental design
A total of 20 female rats were observed by vaginal cytol-
ogy for 15  days, always in the morning, to verify that 
all of the female rats were cycling normally. After the 
vaginal cytology tests, these rats were ovariectomized 
between 8:00 AM and 10:00 AM and remained undis-
turbed for 15  days to deplete hormone stores (Vignon 
and Rochefort 1976). These OVX female rats were then 
divided into four equal groups. Two groups received 
estrogen (50  µg/kg, i.p., 54  h before testing) and saline 
(ES group, n = 4) or 3.5 mg/kg morphine (i.p.; EM group, 
n  =  4) 2  h before euthanasia. The other two groups 
received saline solution 54 and 2  h before saline (SS 
group, n = 4) or 3.5 mg/kg morphine (SM group, n = 4) 
treatment. Oprm1, Oprd1, and Oprk1 gene expression 
was evaluated in the striatum, hypothalamus, and PAG. 
An OVX group, called white, remained untreated (W 
group, n = 4).
Statistical analysis
The results are expressed as mean ± SEM. Homoscedas-
ticity was verified using an F test or Bartlett’s test. Nor-
mality was verified using the Kolmogorov–Smirnov test. 
Differences in scores between more than two groups 
were assessed by one-way analysis of variance (ANOVA) 
followed by Tukey’s multiple-comparison test. The results 
were considered significant at p < 0.05.
Conclusions
In this study we evaluated the effects of acute treatment 
with morphine on the expression of the Oprm1, Oprk1, 
and Oprd1 opioid genes in some cerebral areas that could 
be modulated by sexual hormones in ovariectomized 
female rats. The results showed that these genes expres-
sion could be changed in response to morphine, espe-
cially by estrogen dependence, supporting the hypothesis 
of a functional role of ovarian hormones in opioid recep-
tor-mediated functional adaptations in the female brain. 
This is very important because whereas this study used 
ovariectomized female rats, the use of opioid analgesics 
in intact females could change parameters of reproduc-
tion and promote a injury in maternal homeostasis, that 
could influence parental care and generate alterations in 
offspring in adulthood life.
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